Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42899 | 0.88 | CYP3A4 (0.43) | CYP3A4GABRA1GABRB2ALDH1A1HPGD | |
| SCHEMBL10610591 | 0.85 | CYP3A4 (0.41) | CYP3A4GABRA1GABRB2ALDH1A1HPGD | |
| SCHEMBL2169591 | 0.85 | CYP3A4 (0.52) | CYP3A4GABRA1GABRB2ALDH1A1HPGD | |
| SCHEMBL109280 | 0.83 | CYP3A4 (0.62) | CYP3A4GABRA1GABRB2ALDH1A1HPGD | |
| SCHEMBL1356140 | 0.81 | CYP3A4 (0.50) | CYP3A4GABRA1GABRB2ALDH1A1HPGD | |
| SCHEMBL29369823 | 0.81 | CYP3A4 (0.50) | CYP3A4GABRA1GABRB2ALDH1A1HPGD | |
| SCHEMBL2170759 | 0.80 | GABRA1 (0.49) | CYP3A4GABRA1GABRB2ALDH1A1HPGD | |
| SCHEMBL7181943 | 0.79 | CYP3A4 (0.36) | CYP3A4GABRA1GABRB2 | |
| SCHEMBL10610758 | 0.78 | AR (0.38) | CYP3A4GABRA1GABRB2ALDH1A1HPGD | |
| SCHEMBL28570936 | 0.77 | CYP3A4 (0.56) | CYP3A4GABRA1GABRB2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105408444-A | Proppant with enhanced interparticle bonding | PREFERRED TECH LLC | 2016-03-16 | — | — | CN | disclosed |